☆ 4.8 Article

Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People

FRONTIERS IN IMMUNOLOGY (2021)

Related references

Note: Only part of the references are listed.

Editorial Material Geriatrics & Gerontology

Efficacy and safety of COVID-19 vaccines in older people

Roy L. Soiza et al.

Summary: The safety and efficacy of COVID-19 vaccines in older people are crucial for their success, but there is currently a lack of data. While some Phase III trials have made efforts to recruit older people, those with co-morbidities and frailty have still been largely excluded. Older people, their carers, and healthcare professionals will need to make decisions on vaccination acceptance based on limited evidence.

AGE AND AGEING (2021)

Add to Collection

Article Geriatrics & Gerontology

Impact of COVID-19 on care-home mortality and life expectancy in Scotland

Jennifer K. Burton et al.

Summary: This study quantified the mortality burden of COVID-19 on care-home residents and found it to be common. Results showed that COVID-19 infection has led to the loss of substantial years of life in care-home residents aged 70 years and over in Scotland. Prioritizing vaccination for care-home residents aged 70 and over is justified not only in terms of total deaths, but also in terms of years of life lost.

AGE AND AGEING (2021)

Add to Collection

Editorial Material Immunology

Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents

David H. Canaday et al.

Summary: After receiving the BNT162b2 messenger RNA vaccine, nursing home residents had antibody neutralization titers one-quarter of healthcare workers who were naive to SARS-CoV-2.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Geriatrics & Gerontology

Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study

Sergio Salmeron Rios et al.

Summary: In a longitudinal cohort study in long-term care facilities in Albacete, Spain, 134 older adults aged >= 65 years received two doses of the BNT162b2 mRNA COVID-19 vaccine, with antibody levels measured 21.9 days after each dose. The vaccine was found to be safe and produced immunogenicity in older adults, regardless of their frailty and disability profiles. Residents with prior COVID-19 infection showed increased antibody levels post-vaccination.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Jingxin Li et al.

Summary: The messenger RNA vaccine candidate BNT162b1, encoding the receptor-binding domain of the SARS-CoV-2 spike protein, showed safety and high levels of humoral and T cell responses in an Asian population, including younger and older Chinese adults. Local reactions and systemic events post-vaccination were generally dose-dependent, transient, and mild to moderate.

NATURE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

Joseph E. Ebinger et al.

Summary: Virus-specific antibody levels after a single dose of the BNT162b2 vaccine in individuals previously infected with SARS-CoV-2 are similar to levels after two doses of the vaccine in infection-naive individuals. Post-vaccine symptoms were more prominent for those with prior infection after the first dose, but symptomology was similar between groups after the second dose.

NATURE MEDICINE (2021)

Add to Collection

Article Immunology

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay

Gaetano Donofrio et al.

Summary: COVID-19, caused by the highly infectious coronavirus SARS-CoV-2, is a global ongoing pandemic that has triggered intense scientific research on developing vaccines. Efforts are focused on quantifying neutralizing antibodies induced by vaccination to validate protection and control the pandemic, with a simplified neutralization assay being developed for easier implementation in medical laboratories. This innovative approach aims to improve the vaccination campaign and adapt to different coronavirus variants for enhanced efficacy.

VACCINES (2021)

Add to Collection

Article Multidisciplinary Sciences

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Dami A. Collier et al.

Summary: Elderly individuals, especially those above eighty, show lower immune responses and neutralization abilities against variants of concern after the first vaccine dose, but this improves after the second dose. They have higher frequencies of spike-specific memory B cells but reduced somatic hypermutation of class-switched cells. Production of interferon-gamma and interleukin-2 by SARS-CoV-2 spike-specific T cells is lower in older participants, predominantly by CD4 T cells.

NATURE (2021)

Add to Collection

Article Immunology

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

Lisa Mueller et al.

Summary: The study compared antibody responses to the BNT162b2 COVID-19 vaccine in young vaccinees below 60 and elderly vaccinees over 80. The elderly group had lower antibody titers and a lower frequency of neutralizing antibodies post-vaccination, indicating a potential need for closer monitoring or different vaccination strategies for this population.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

Tatjana Schwarz et al.

Summary: After receiving the BNT162b2 vaccine, elderly individuals in Germany showed delayed and reduced antibody and T-cell responses compared to healthcare workers, indicating the potential need for additional immunizations for this age group. Nonpharmaceutical interventions for coronavirus disease remain crucial based on this data.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Cell Biology

A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations

Ludivine Grzelak et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Microbiology

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals

Etienne Brochot et al.

FRONTIERS IN MICROBIOLOGY (2020)

Add to Collection

Letter Medicine, General & Internal

The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019-Missing the Target

Benjamin K. I. Helfand et al.

JAMA INTERNAL MEDICINE (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

The Impact of COVID-19 Pandemic on Long-Term Care Facilities Worldwide: An Overview on International Issues

Dana-Claudia Thompson et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Add to Collection

Article Immunology

Severe SARS-CoV-2 patients develop a higher specific T-cell response

Julie Demaret et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)

Add to Collection

Review Geriatrics & Gerontology

Immunosenescence and human vaccine immune responses

Stephen N. Crooke et al.

IMMUNITY & AGEING (2019)

Add to Collection

Review Immunology

The twilight of immunity: emerging concepts in aging of the immune system

Janko Nikolich-Zugich

NATURE IMMUNOLOGY (2018)

Add to Collection

Article Geriatrics & Gerontology

High TNF-α levels in resting B cells negatively correlate with their response

Daniela Frasca et al.

EXPERIMENTAL GERONTOLOGY (2014)

Add to Collection

Article Nutrition & Dietetics

Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients

O Bouillanne et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2005)

Add to Collection

Article Medicine, General & Internal

A global clinical measure of fitness and frailty in elderly people

K Rockwood et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.